ACT-129968

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ACT-129968, covering 2018-07-09 to 2019-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis [Phase 2]